Summary & Overview
CPT 78699: Unlisted Nervous System Diagnostic Nuclear Medicine Procedure
CPT code 78699 designates an unlisted diagnostic nuclear medicine procedure of the nervous system and is used when no specific CPT code accurately describes the service performed. Nationally, unlisted codes like 78699 are important for reporting novel, highly specialized, or infrequently performed nuclear medicine studies of the brain and related nervous system structures. Proper use affects claims processing, clinical documentation, and payer review because payers typically require detailed procedure descriptions and supporting documentation to adjudicate unlisted service claims.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find guidance on the clinical context in which 78699 is applied, typical sites of service where these procedures occur, and practical considerations for billing unlisted nervous system nuclear medicine studies. The publication provides benchmarking context where available, highlights common documentation expectations for payers, and summarizes policy considerations that influence coverage and reimbursement for unlisted nuclear medicine services.
Data not available in the input is noted where applicable. This national overview is intended to inform billers, coders, and policy professionals about the role and implications of using CPT code 78699 for nervous system diagnostic nuclear medicine procedures.
Billing Code Overview
CPT code 78699 is an unlisted nervous system diagnostic nuclear medicine procedure. It is used to report a diagnostic nuclear medicine service focused on the nervous system when no specific CPT code exists for the performed procedure.
-
Service type: Diagnostic nuclear medicine procedure for the nervous system
-
Typical site of service: Hospital outpatient department, ambulatory imaging center, or other diagnostic imaging facility
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with progressive balance disturbance, intermittent headaches, and unexplained episodes of transient neurologic deficits is referred by neurology for a specialized nuclear medicine study of the nervous system that does not have a dedicated CPT code. The ordering neurologist requests a targeted diagnostic functional imaging study—such as a novel radiotracer-based cerebral blood flow or neurotransmitter receptor scan—to evaluate suspected cerebrovascular insufficiency or degenerative neurologic disease when standard imaging (MRI/CT) is inconclusive. The patient arrives at an outpatient nuclear medicine department. Pre-procedure verification includes allergy and medication review, consent, and pregnancy status if applicable. The nuclear medicine technologist administers the radiopharmaceutical per institutional protocol, performs dynamic and static imaging with gamma camera/SPECT or PET, and documents radiotracer, administered activity, and imaging times. A nuclear medicine physician interprets the images, generates a report describing findings and limitations, and includes any technical factors requiring a potential modifier (for example, increased procedural complexity). Billing uses 78699 to report this atypical nervous system diagnostic nuclear medicine procedure, with technical and professional components separated as applicable using modifier TC or 26 when only one component is billed. Typical sites of service are hospital outpatient imaging, freestanding imaging centers, or academic medical center nuclear medicine departments. Typical patient scenario: older adult with atypical neurologic symptoms or equivocal standard imaging undergoing an investigational or non‑coded radionuclide brain study to assess perfusion, receptor binding, or other functional parameters.
Coding Specifications
| Modifier |
|---|